Mendelian randomization based on immune cells in diabetic nephropathy

Area of Science:

• Immunology
• Genetics
• Nephrology

Background:

• Diabetic kidney disease (DKD) is a major cause of kidney failure, yet its immunological underpinnings are not well understood.
• Genetic studies have identified immune mechanisms in kidney diseases, but DKD's specific immune basis remains unclear.

Purpose of the Study:

• To investigate the causal relationships between immune cell traits and the risk of developing diabetic kidney disease (DKD).
• To leverage Mendelian randomization to explore immunophenotypes associated with DKD.

Main Methods:

• Utilized two-sample Mendelian randomization (MR) analysis on FinnGen data, including 1032 DKD cases and 451,248 controls.
• Analyzed 731 immunocyte genome-wide association study (GWAS) summaries.
• Performed sensitivity analyses, heterogeneity checks, and False Discovery Rate (FDR) correction for robust results.

Main Results:

• Nine immunophenotypes showed significant associations with DKD after FDR correction (p<0.05).
• Elevated CD24, CD3 in regulatory T cell (Treg) subsets, CD39+ CD4+ T cells, and CD33- HLA-DR- activated cells (AC) correlated with increased DKD risk.
• CD27 in B cells and SSC-A in CD4+ T cells showed inverse correlations with DKD risk.

Conclusions:

• Immune cell profiles are significantly associated with diabetic kidney disease (DKD).
• These findings highlight potential immune targets and pathways relevant to DKD pathogenesis.
• Further research into the role of specific immune cells in DKD could inform future clinical strategies.